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From gender benders to brain benders (and beyond!) 1 
 2 
Editorial 3 
Alex T Ford 4 
aInstitute of Marine Sciences, School of Biological Sciences, University of Portsmouth, Ferry Road, 5 
Portsmouth, Hampshire, PO4 9LY, UK 6 
E-mail address: alex.ford@port.ac.uk  7 
Tel.: +44-2392-845805; fax: +44-2392-845800. 8 
 9 
The impact of pharmaceuticals in the environment has been a concern for several decades (Cleuvers, 10 
2003; Ferrari et al, 2003; Fent et al, 2006, Santos et al, 2010). Following on from the field of endocrine 11 
disrupting chemicals (EDCs) in the early 1990s, where awareness to population level effects of sub-lethal 12 
chemicals were raised, the scientific community was alerted to the potential impact of antidepressants 13 
over a decade ago (Fong, 1998; Fong, 2001, Brooks et al 2003). A considerable amount of research on 14 
EDCs was based around synthetic estrogens and estrogen mimics/agonists (Tyler et al, 1998; Lange et al 15 
2001; Sumpter and Johnson, 2005) resulting in a focussed international research effort that culminated 16 
in a vast body of research. Interestingly, and despite the fact that in some countries the prescriptions for 17 
contraceptive pills and those for antidepressants are broadly similar (~8-9% of the population; US DHHS 18 
report, 2012); and both compounds are found at low ng/L concentration in the environment, the body 19 
of ecotoxicological work covering effects of synthetic estrogens hugely grosses that of the 20 
antidepressants. Why there hasn’t been more recent into the antidepressants is not entirely clear but 21 
may have occurred for a variety of reasons. Firstly, the numbers of studies recording these compounds 22 
in aquatic systems were previously limited and secondly the effects of antidepressants that were 23 
recorded were at relatively high concentrations arguably due to the endpoints available at the time and 24 
thus perhaps did not stimulate the field. In addition, the field of behavioural ecotoxicology, despite 25 
coming a long way is still developing. Therefore, it is arguably more difficult to extrapolate aberrant 26 
behavioural of aquatic organisms into risk assessment compared to impacts observed on reproductive 27 
systems, growth and mortality. And finally, the research funding for the field of ecotoxicology is ever 28 
transient and antidepressants are one small group of pharmaceuticals amongst many thousands 29 
needing to be fully evaluated for their impact on the environment. 30 
 31 
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Recently, an increasing number of studies have raised the concerns over the impact of antidepressants 32 
in the aquatic environment due to effects on aquatic organisms (both invertebrates and vertebrates) 33 
being observed at concentrations at very low and environmentally relevant concentrations (Shultz et al, 34 
2011; Di Poi et al 2013; Franselitti et al 2003; Guler and Ford, 2010; De Lang et al, 2006; Fong and Hoy, 35 
2012) even down into the pg/L range. For this reason it was decided to put together this special edition 36 
with the view to consolidating the most up to date research and views on the topic, to generate debate 37 
and aid researchers and regulators in evaluating the risk posed by these special biologically active 38 
pharmaceuticals. Having decided to entitle this editorial from gender benders to brain benders it is 39 
worth pointing out one of the major shortcomings in this title. A large focus on the effects of 40 
antidepressants, as one expect from their therapeutic effect in humans, has been on behavioural 41 
endpoints observed across a range of Phyla. However, it is also important to note that the 42 
antidepressants were designed to target neurohormones (e.g. serotonin, dopamine and epinephrine) 43 
which are involved in a wide variety of biological processes “beyond” just behaviour. 44 
 45 
The special edition starts with a review whereby we provide an overview of the neuroendocrine systems 46 
of the Mollusca and Crustacea (Fong and Ford, 2014). Based on the biology and reviewing the current 47 
literature on the effects of antidepressants in these groups, this paper notes gaps in our current 48 
knowledge and highlight the increasing number of effects demonstrated at environmentally relevant 49 
concentrations and non-monotonic concentration curves. Interestingly, antidepressants look like strong 50 
candidates for model compounds for studying non-monotonic concentrations effects (Vandenberg et al, 51 
2012), especially given their neuronal and hormonal activity. Following this, Franzelliti et al (2014) 52 
highlight that other adverse outcome pathways (AOPs) need to be considered beyond those solely 53 
related to the mammalian mode of action (MOA) for which the drug was designed. Through 54 
investigating a wide variety of biomarkers the authors report significant effects of the SSRI fluoxetine on 55 
a marine mussel at sub-ng/L concentrations. Similarly, Bringoff et al (2014) studying the effects of 56 
fluoxetine on a freshwater mussel following a 67-d exposure report altered behavioural and metabolic 57 
endpoints at higher concentrations. Providing further evidence of environmentally relevant and novel 58 
adverse outcome pathways, Di Poi et al (2014) report on the effects of the fluoxetine on crypsis in a 59 
cuttlefish. Completing the section on invertebrates, Bossus et al (2014) report on the effects of 60 
fluoxetine and sertraline on behaviour and gene expression in a marine amphipod. The authors report 61 
effects as low as 1ng/L and interestingly in some instances behavioural alterations were seen within 1hr 62 
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of exposure. Investigations into the transcriptional changes highlight plausible links between SSRI 63 
exposure and altered phototransduction pathways. 64 
 65 
Providing a cautionary tone to these studies, a commentary from Sumpter et al (2014) urges scientists 66 
and the scientific community to replicate some of these studies, given the low pg-ng/L being reported. 67 
They report this is especially important given the lack of concentration-response relationships, the use 68 
of none-standard endpoints and considerable differences in observed effects between species given the 69 
‘read-across’ hypothesis (see Hugget et al. 2003; Rand-Weaver et al. 2013; and further commentary by 70 
Sumpter and Margiotta-Casaluci, 2013). 71 
 72 
Brooks (2014) "Fish on Prozac (and Zoloft): Ten Years Later" provides a historical overview of the work 73 
undertaken and lessons learnt by Brooks and colleagues and in the area of antidepressant ecotoxicology 74 
since the publication of their early research ten years ago. In additio , Brooks (2014) highlights the use 75 
of probabilistic hazard assessment and fish plasma modelling approaches with SSRIs and tricyclic 76 
antidepressants and suggests that these drugs are predicted to result in therapeutic hazard to fish 77 
(internal fish plasma level equalling mammalian therapeutic dose) when exposed to water (inhalational) 78 
at or below 1 μg/L. 79 
 80 
Beginning the section on fish, Yang et al (2014) studied the effects of the tricyclic antidepressant, 81 
amitriptyline (1ng-1mg/L), on growth and a range of physiological and biochemical biomarkers in 82 
zebrafish embryos. The authors report significant effects as low as 10ng/L and highlight a range of U and 83 
inverted-U shaped concentration-response curves. Next follows a group of studies looking at 84 
behavioural endpoints in fish exposed to variety of antidepressants. Firstly, Weinberger and Klaper 85 
(2014) using fathead minnows, reported a variety of altered mating behaviours including nest building 86 
and defending in male fish with exposure to 1µg/L fluoxetine. Higher doses altered predator avoidance 87 
behaviour and feeding and interestingly 100µg/L exposures resulted in increased mortality in females 88 
caused by male aggression. Secondly, Hedgespath et al (2014) studied the effects of the SSRI sertraline 89 
on feeding in the Eurasian perch and found that the ability to prey on Daphnia magna was impaired at 90 
83 and 300 µg/L at two different stocking densities but not at lower concentrations (0.12 µg/L). In 91 
another feeding study, Bisesi et al (2014) investigated the ability of hybrid striped bass to prey upon 92 
fathead minnows following exposure to the SNRI venlafaxine (0-500 µg/L) and demonstrated increased 93 
time to capture prey at higher concentrations. The authors also reported significant reductions in brain 94 
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serotonin levels in exposed fish, however, no effects on brain dopamine or epinephrine were observed. 95 
Thirdly, Olsén et al (2014) investigated the effects of the SSRI citropram on reproductive and non-96 
reproductive behaviour in the Endler guppy and report a variety of anxiolytic behaviours, including 97 
reduced freezing behaviour in both males and females and greater exploration of upper parts of the 98 
aquaria in male specimens. Finally, Conners et al (2014) highlight that although the primary 99 
pharmaceutical site for the action of SSRIs is serotonin transporters (SERTs), others are known to target 100 
5-HT1A receptors as well as SERT. With this in mind Conners et al (2014) investigated the 5-HT and 101 
cannabinoid (CB) receptors in zebrafish and used an anxiolytic behaviour tests against 5-HT and CB 102 
agonists.  103 
 104 
Two studies close the special edition whereby two different fish species were exposed to the 105 
antiepileptic and mood stabilising drug, Carbamazepine (CBZ). Hampel et al (2014) looked at the 106 
transcriptomic responses in salmon exposed to CBZ using a 17K cDNA microarray. The study observed 107 
enrichment and down-regulation effects across a range of biological processes including focal adhesion, 108 
extracellular matrix – receptor interaction pathways, apoptotic process, extracellular matrix 109 
organization and heme biosynthesis. Moving from molecular to population level effects, Wilson et al 110 
(2014) using the zebrafish model, observed generational effects in fish exposed to the mood stabilizer 111 
Carbamazepine (CBZ) and plasma lipid reducing drug Gemfibrozil (GEM) at 10µg/L. Interestingly, 112 
reciprocal crosses between F1 group controls with CBZ or GEM exposed F1 individuals indicated male 113 
exposure induced greater effects. These male specific effects were also observed in courtship behaviour 114 
and sperm morphology although these effects were drug specific. 115 
 116 
It is hoped this special edition will spark some debate within the field and assist in moving the science 117 
forward. In addition, we hope the international community take on the challenge to test the 118 
repeatability of these surprisingly low dose effects and address some of the concerns raised in these 119 
studies. We would strongly encourage any opinions the scientific community may have on the science 120 
presented in this edition to submit their views under the “letters to the editor” section.  121 
 122 
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